Built to close the 80-year dispensing gap.
BioBloomBoutique Pvt. Ltd. — a DPIIT-registered medtech founded in India, building patent-protected hardware that makes the government's digital health investment finally pay off.
Three builders. One mission.
Eliminating India's ₹1,765 Cr hospital drug leakage problem — with AI, hardware, and zero tolerance for the status quo.
Ajay Shinde
Founder & CEO
The vision behind BioBloomBoutique. Ajay identified India's silent ₹1,765 Cr drug leakage crisis in government hospitals and built BBB from the ground up — patent, pilot, product, and policy. Driving B2G strategy, Maharashtra Health partnerships, ABDM-native architecture, and the pre-seed raise.
1st Runner Up — Venture Vibe 2026
Business Plan Competition, DY Patil University · VPSM
Direct meeting — Principal Secretary, Maharashtra Health
PS-2 E. Ravinderan IAS · Readiness to collaborate on pilot
KEM Hospital Mumbai
Active pilot under Ethics & Finance Committee review
Shubham Bhosale
Co-Founder & CFO
Owns BBB's financial architecture end-to-end. Built the 3-year model, BOOT deployment economics, and pre-seed raise structure across govt, private, and NHM bulk procurement.
Architect — BBB 3-year financial model & ₹60 Cr valuation SAFE structure
Arjun Sable
CTO
IIT Bombay alumnus. Leads all engineering — embedded hardware, AI dispensing logic, ABDM API integration, and the closed-loop E-Rx to dispense pipeline.
National Recognition — Certificate, Ministry of Home Affairs, New Delhi
3 years of market research and development.
From ground-level hospital study to product architecture — designed, then molded to India's governance requirements.
Phase 01
Ground-level study
Spent years inside hospital pharmacies and wards mapping the real flow of prescription, stock, dispense and billing.
Phase 02
Product architecture
Built the ADM + WVM hardware stack around the 5 Rights of medication: right patient, drug, dose, route and time.
Phase 03
GovStack alignment
Molded the platform to India's digital health standards: ABDM · FHIR R4 · NHCX · UHI · NHM MIS · E-Sanjeevani · E-Aushadhi · MMGPA.
Full company timeline and investor deck arrive in Phase C.